Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 50 articles:
HTML format



Single Articles


    November 2021
  1. HLAKA L, Ozturk M, Chia JE, Jones SS, et al
    IL-4i1 regulates immune protection during Mycobacterium tuberculosis infection.
    J Infect Dis. 2021 Nov 5. pii: 6421699. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  2. ARRIAGA MB, Araujo-Pereira M, Barreto-Duarte B, Nogueira B, et al
    The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study.
    J Infect Dis. 2021 Oct 15. pii: 6398049. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  3. CHEN Y, Ji L, Liu Q, Li J, et al
    Lesion Heterogeneity and Long-Term Heteroresistance in Multidrug-Resistant Tuberculosis.
    J Infect Dis. 2021;224:889-893.
    PubMed     Abstract available


    July 2021
  4. HALLIDAY A, Masonou T, Tolosa-Wright MR, Guo Y, et al
    Defining the Role of Cellular Immune Signatures in Diagnostic Evaluation of Suspected Tuberculosis.
    J Infect Dis. 2021 Jul 31. pii: 6332782. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  5. ARRIAGA MB, Rocha MS, Nogueira B, Nascimento V, et al
    The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts.
    J Infect Dis. 2021 May 19. pii: 6278117. doi: 10.1093.
    PubMed     Abstract available


  6. PARVEEN S, Lun S, Urbanowski ME, Cardin M, et al
    Effective host-directed therapy for tuberculosis by targeted depletion of myeloid-derived suppressor cells and related cells using a diphtheria toxin-based fusion protein.
    J Infect Dis. 2021 May 6. pii: 6270734. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  7. DUFFY FJ, Olson GS, Gold ES, Jahn A, et al
    A contained Mycobacterium tuberculosis mouse infection model predicts active disease and containment in humans.
    J Infect Dis. 2021 Mar 10. pii: 6167837. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  8. MUDDE SE, Alsoud RA, van der Meijden A, Upton AM, et al
    Predictive modeling to study the treatment-shortening potential of novel tuberculosis drug regimens, towards bundling of preclinical data.
    J Infect Dis. 2021 Feb 19. pii: 6145049. doi: 10.1093.
    PubMed     Abstract available


  9. RAO MUVVA J, Ahmed S, Rekha RS, Kalsum S, et al
    Immunomodulatory agents combat multidrug-resistant tuberculosis by improving antimicrobial immunity.
    J Infect Dis. 2021 Feb 19. pii: 6145048. doi: 10.1093.
    PubMed     Abstract available


  10. DUBEY N, Khan MZ, Kumar S, Sharma A, et al
    Mycobacterium tuberculosis PPiA interacts with host integrin receptor to exacerbate disease progression.
    J Infect Dis. 2021 Feb 13. pii: 6134355. doi: 10.1093.
    PubMed     Abstract available


  11. LAI CC, Tehrani B, Yungtum G, Hsu WT, et al
    Association between the use of statins and risk of tuberculosis: a real-world analysis.
    J Infect Dis. 2021 Feb 8. pii: 6131374. doi: 10.1093.
    PubMed    


  12. BEHR MA, Divangahi M, Schurr E
    Lessons From Bacille Calmette-Guerin for SARS-CoV-2 Vaccine Candidates.
    J Infect Dis. 2021;223:189-191.
    PubMed     Abstract available


    January 2021
  13. STEIN CM, Benchek P, Bartlett J, Igo RP, et al
    Methylome-wide analysis reveals epigenetic marks associated with resistance to tuberculosis in HIV-infected individuals from East Africa.
    J Infect Dis. 2021 Jan 5. pii: 6064776. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  14. BARBOSA BOMFIM CC, Pinheiro Amaral E, Santiago-Carvalho I, Almeida Santos G, et al
    Granulocytic Myeloid-Derived Suppressor Cells Aggravate Tuberculosis Caused by Hypervirulent Mycobacteria.
    J Infect Dis. 2020 Nov 18. pii: 5989003. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  15. HJORT K, Juren P, Toro JC, Hoffner S, et al
    Dynamics of extensive drug resistance evolution of Mycobacterium tuberculosis in a single patient during 9 years of disease and treatment.
    J Infect Dis. 2020 Oct 12. pii: 5921146. doi: 10.1093.
    PubMed     Abstract available


  16. AGARWAL S, Tiwari P, Deep A, Kidwai S, et al
    Corrigendum to: System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis.
    J Infect Dis. 2020 Oct 7. pii: 5918919. doi: 10.1093.
    PubMed    


    September 2020
  17. LOONEY MM, Lu Y, Karakousis PC, Halushka MK, et al
    Mycobacterium tuberculosis infection drives mitochondria-biased dysregulation of host tRNA-derived fragments.
    J Infect Dis. 2020 Sep 22. pii: 5909842. doi: 10.1093.
    PubMed     Abstract available


  18. ZHANG S, Li G, Bi J, Guo Q, et al
    Functional nucleotide polymorphisms up-regulating transforming growth factor beta1 expression are associated with increased tuberculosis susceptibility.
    J Infect Dis. 2020 Sep 16. pii: 5906652. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  19. EISENHUT M
    The influence of cigarette smoke on results of hematological and immunological investigations in patients exposed to Mycobacterium tuberculosis.
    J Infect Dis. 2020 Jul 29. pii: 5877958. doi: 10.1093.
    PubMed    


  20. CAMPBELL N, Verrall AJ, Donkor S, Sutherland JS, et al
    BCG protection against Mycobacterium tuberculosis infection by level of exposure in The Gambia.
    J Infect Dis. 2020 Jul 8. pii: 5868549. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  21. DUTTA NK, Karakousis PC
    Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?
    J Infect Dis. 2020;222:336-337.
    PubMed    


    May 2020
  22. OSAWA T, Watanabe M, Morimoto K, Okumura M, et al
    Serum procalcitonin levels predict mortality risk in patients with pulmonary tuberculosis: a single-center prospective observational study.
    J Infect Dis. 2020 May 23. pii: 5843442. doi: 10.1093.
    PubMed     Abstract available


  23. HE X, Eddy JJ, Jacobson KR, Henderson AJ, et al
    Enhanced HIV-1 Replication in CD4+ T Cells Derived from Individuals with Latent Mycobacterium tuberculosis Infection.
    J Infect Dis. 2020 May 16. pii: 5838261. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  24. KUMAR NP, Kathamuthu GR, Moideen K, Banurekha VV, et al
    Strongyloides stercoralis coinfection is associated with greater disease severity, higher bacterial burden and elevated plasma matrix metalloproteinases in pulmonary tuberculosis.
    J Infect Dis. 2020 Apr 20. pii: 5822617. doi: 10.1093.
    PubMed     Abstract available


  25. SULIMAN S, Gela A, Mendelsohn SC, Iwany SK, et al
    Peripheral blood mucosal-associated invariant T (MAIT) cells in tuberculosis patients and healthy Mycobacterium tuberculosis-exposed controls.
    J Infect Dis. 2020 Apr 8. pii: 5817894. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  26. KAUSHAL D
    The Comeback Kid: BCG.
    J Infect Dis. 2020;221:1031-1032.
    PubMed    


    February 2020
  27. LU LL, Das J, Grace PS, Fortune SM, et al
    Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis.
    J Infect Dis. 2020 Feb 15. pii: 5736363. doi: 10.1093.
    PubMed     Abstract available


  28. EISINGER RW, Embry AC, Read SW, Fauci AS, et al
    2019: A Banner Year for Tuberculosis Research.
    J Infect Dis. 2020 Feb 11. pii: 5719366. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  29. CLICK ES, Kurbatova E, Alexander H, Dalton TL, et al
    Isoniazid- and Rifampin-Resistance Mutations Associated with Resistance to Second-line Drugs and with Sputum Culture Conversion.
    J Infect Dis. 2020 Jan 31. pii: 5718252. doi: 10.1093.
    PubMed     Abstract available


  30. BIGELOW KM, Deitchman AN, Li SY, Barnes-Boyle K, et al
    Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis.
    J Infect Dis. 2020 Jan 29. pii: 5716916. doi: 10.1093.
    PubMed     Abstract available


  31. SONG Y, Hussain T, Wang J, Liao Y, et al
    Mitochondrial Transcription Factor A Regulates Mycobacterium bovis-Induced IFN-beta Production by Modulating Mitochondrial DNA Replication in Macrophages.
    J Infect Dis. 2020;221:438-448.
    PubMed     Abstract available


    December 2019
  32. HU Z, Lowrie DB, Fan XY
    Statins as adjunctive therapy against tuberculosisthe balance between statin-induced anti-TB effect and trained immunity suppression.
    J Infect Dis. 2019 Dec 24. pii: 5686380. doi: 10.1093.
    PubMed    


  33. ALBERTO CHORENO-PARRA J, Bobba S, Rangel-Moreno J, Ahmed M, et al
    Mycobacterium tuberculosis HN878 infection induces human-like B cell follicles in mice.
    J Infect Dis. 2019 Dec 13. pii: 5674951. doi: 10.1093.
    PubMed     Abstract available


  34. TORNHEIM JA, Madugundu AK, Paradkar M, Fukutani KF, et al
    Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response among Indian Children.
    J Infect Dis. 2019 Dec 4. pii: 5651247. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  35. PEETLUK LS, Rebeiro PF, Cordeiro-Santos M, Kritski A, et al
    Lack of weight gain during the first two months of treatment and HIV independently predict unsuccessful treatment outcomes in tuberculosis.
    J Infect Dis. 2019 Nov 14. pii: 5625394. doi: 10.1093.
    PubMed     Abstract available


  36. STOCKDALE L, Nash S, Farmer R, Raynes J, et al
    Cytomegalovirus antibody responses associated with increased risk of TB disease in Ugandan adults.
    J Infect Dis. 2019 Nov 5. pii: 5613526. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  37. SIMMONS JD, Peterson GJ, Campo M, Lohmiller J, et al
    Nicotinamide limits replication of Mycobacterium tuberculosis and BCG within macrophages.
    J Infect Dis. 2019 Oct 31. pii: 5610259. doi: 10.1093.
    PubMed     Abstract available


  38. STEIN CM, Mayanja-Kizza H, Hawn TR, Boom WH, et al
    Importance of study design and phenotype definition in ongoing studies of resistance to latent M. tuberculosis infection.
    J Infect Dis. 2019 Oct 30. pii: 5609437. doi: 10.1093.
    PubMed    


  39. SAKAMURI RM, Singh KK, Ryndak MB, Laal S, et al
    Evolution of antibodies to epitopes of PE_PGRS51 in the spectrum of active pulmonary tuberculosis.
    J Infect Dis. 2019 Oct 23. pii: 5602685. doi: 10.1093.
    PubMed     Abstract available


  40. DUTTA NK, Bruiners N, Zimmerman MD, Tan S, et al
    Adjunctive host-directed therapy with statins improves tuberculosis-related outcomes in mice.
    J Infect Dis. 2019 Oct 12. pii: 5586531. doi: 10.1093.
    PubMed     Abstract available


  41. NATHAVITHARANA RR, Yoon C, Macpherson P, Dowdy DW, et al
    Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests.
    J Infect Dis. 2019;220.
    PubMed     Abstract available


  42. GEORGHIOU SB, Schumacher SG, Rodwell TC, Colman RE, et al
    Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility Tests.
    J Infect Dis. 2019;220.
    PubMed     Abstract available


  43. DRAIN PK, Gardiner J, Hannah H, Broger T, et al
    Guidance for Studies Evaluating the Accuracy of Biomarker-Based Nonsputum Tests to Diagnose Tuberculosis.
    J Infect Dis. 2019;220.
    PubMed     Abstract available


  44. SCHUMACHER SG, Wells WA, Nicol MP, Steingart KR, et al
    Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.
    J Infect Dis. 2019;220.
    PubMed     Abstract available


  45. DENKINGER CM, Schumacher SG, Gilpin C, Korobitsyn A, et al
    Guidance for the Evaluation of Tuberculosis Diagnostics That Meet the World Health Organization (WHO) Target Product Profiles: An Introduction to WHO Process and Study Design Principles.
    J Infect Dis. 2019;220.
    PubMed     Abstract available


    July 2019
  46. HORTLE E, Johnson KE, Johansen MD, Nguyen T, et al
    Thrombocyte Inhibition Restores Protective Immunity to Mycobacterial Infection in Zebrafish.
    J Infect Dis. 2019;220:524-534.
    PubMed     Abstract available


    June 2019
  47. AFKHAMI S, Lai R, D'Agostino MR, Vaseghi-Shanjani M, et al
    Single-dose mucosal immunotherapy with chimpanzee adenovirus-based vaccine accelerates TB disease control and limits its rebound following antibiotic cessation.
    J Infect Dis. 2019 Jun 13. pii: 5519039. doi: 10.1093.
    PubMed     Abstract available


  48. HU Z, Lu SH, Lowrie DB, Fan XY, et al
    Reply to Tonby et al.
    J Infect Dis. 2019;220:176-178.
    PubMed    


    May 2019
  49. KROEZE S, Wit FW, Rossouw TM, Steel HC, et al
    Plasma biomarkers of HIV-related systemic inflammation and immune activation in sub-Saharan Africa before and during suppressive antiretroviral therapy.
    J Infect Dis. 2019 May 14. pii: 5489039. doi: 10.1093.
    PubMed     Abstract available


    October 2018
  50. THUONG NTT, Vinh DN, Hai HT, Thu DDA, et al
    Pre-treatment cerebrospinal fluid bacterial load correlates with inflammatory response and predicts neurological events during tuberculous meningitis treatment.
    J Infect Dis. 2018 Oct 9. pii: 5123684. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: